First impression I don't really like it. Management salary is very high I don;t know why...but I could be wrong. Anyway, my money is in about 10 biotech stocks and I don't like to diversify the money on too many stocks unless there is super stock and it is so good, force me to rearrange my portfolio.
Question for you,
1. Do you know when BB loaded the shares? recently? or loaded it long time ago.
2. 12% short shares. I wonder why? this is a small company....
3. Do you know when is the date FDA will approve INTERCEPT system for platelets and plasma??
I need to do more dd on this stock. Thanks for asking.....
To the "real" Dr Wang and any others who might have an opinion . . . I have a friend who is big on NVIV and TGNG (since it received financing from Celgene last week . . . it also had a big run-up yesterday) . . . any thoughts on either/both?
They last loaded an additional 2 million shares in April of this year at 4.40. Fidelity also owns over 6%. Their revenues are $40 million and growing at 10%. The FDA just approved their PMA (Pre-Market Approval) plan to submit Intercept in modules from September of this year and last module submitted first half next year. FDA also agreed to use existing data over 10 years used in their overseas markets.